Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil

Go back to Resources

EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Qualitative Results from NIDA Grant

Go back to Resources

Qualitative Results from NIDA Grant

Authors:

Secondary:

Volume:

Issue:

Abstract:

Go back to Resources

Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy

Go back to Resources

Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy

Go back to Resources

Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E

Go back to Resources

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study

Go back to Resources

The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.

Go back to Resources

Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects

Go back to Resources

A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Go back to Resources

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Transition from On-Site to Remote Site Initiation Activities

Go back to Resources

Transition from On-Site to Remote Site Initiation Activities

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification